Weighing Safety Risks and Efficacy of New Vitrectomy Procedure Option
NOVEMBER 23, 2016
As with all new technologies for surgical procedures there will be questions to be answered about the safety for hypersonic vitrectomy. While human trials have not started yet there are good indications in cadaveric and animal studies.
Speaking at the annual meeting of the American Academy of Ophthalmology in Chicago, Paulo E. Stanga, MD, from the Manchester Royal Eye Hospital, said the procedure he has helped develop "is as effective as the commercially available guillotine technology in removing the vitreous." Stanga said if human trials go well the technology should be available to surgeons at some point in 2017.